Selective Use of Radioiodine in Pediatric Thyroid Cancer—a Paradigm Shift - Top-Institutions - MDSpire

Selective Use of Radioiodine in Pediatric Thyroid Cancer—a Paradigm Shift

  • By

  • Eyal Robenshtok

  • September 21, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Pediatric Oncology
    • Endocrinology
    • Thyroid Cancer Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Pediatric Oncology
    • Surgical Oncology

  • #3

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Epidemiology
    • Pediatric Oncology
    • Endocrine Malignancies

  • #4

    Children’s Hospital of Philadelphia (CHOP)
    Children’s Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Endocrinology
    • Pediatric Oncology
    • Thyroid Cancer

Original Source(s)

Selective Use of Radioiodine in Pediatric Thyroid Cancer—a Paradigm Shift

  • by Eyal Robenshtok

  • September 21, 2024

Related Content

Surgical outcomes of Bethesda System for Reporting Thyroid Cytopathology diagnostic category class I, II, and III thyroid nodules

Climate Vulnerability and Cardiometabolic Health Among Children

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.